INTERNATIONAL PATENT: SHANGHAI HENLIUS BIOTECH, INC., SHANGHAI HENLIUS BIOLOGICS CO., LTD., SHANGHAI HENLIUS BIOSCIENCE CO., LTD. FILES APPLICATION FOR "ANTI-EGFR/MET MULTISPECIFIC ANTIBODIES AND METHODS OF USE"

GENEVA, Feb. 23 -- SHANGHAI HENLIUS BIOTECH, INC. (Room 901, The 9th Floor, Building 1, No. 367 Shengrong Road, (Shanghai) Pilot Free Trade ZonePudong New Area, Shanghai 201210), SHANGHAI HENLIUS BIOLOGICS CO., LTD. (Room 617, Building 29, No.1, Lane 618, Dingyuan RoadSongjiang District, Shanghai 201616), SHANGHAI HENLIUS BIOSCIENCE CO., LTD. (Room 706, 7th Floor, Building 7, No. 1289 Yishan RoadXuhui District, Shanghai 200233) filed a patent application (PCT/CN2025/113968) for "ANTI-EGFR/MET MULTISPECIFIC ANTIBODIES AND METHODS OF USE" on Aug 12, 2025. With publication no. WO/2026/037257, the details related to the patent application was published on Feb 19, 2026.

Notably, the patent application was submitted under the International Paten...